Results 221 to 230 of about 393,042 (353)

Regulation of Glucose Homeostasis by Glucocorticoids.

Advances in Experimental Medicine and Biology, 2015
Taiyi Kuo, Allison E McQueen, Tzu-Chieh Chen, Jen-Chywan Wang   +3 more
semanticscholar   +1 more source

Prescribing of Medication to Prevent Glucocorticoid Harms in Patients With Polymyalgia Rheumatica: A Cross‐Sectional Study and Two Emulated Target Trials in the Clinical Practice Research Datalink Aurum

Arthritis &Rheumatology, EarlyView.
Objective Polymyalgia rheumatica (PMR) is a common indication for long‐term glucocorticoid (GC) treatment. Bone‐protective and gastroprotective medications are recommended for those at high risk of adverse events from GCs, but no trials have evaluated their effectiveness in PMR.
Helen Twohig, David Jenkinson, James Bailey, Samantha Hider, Ian C. Scott, Sara Muller   +5 more
wiley   +1 more source

Pharmacologic Therapies for Active Moderate-to-Severe TED: A Comprehensive Systematic Review. [PDF]

Clin Med Insights Endocrinol Diabetes
Builes-Montaño CE, Román-González A, Arenas-Quintero HM, Aristizábal-Henao N, Cabarcas-Solano MDS, Camargo González J, Castellanos-Pinedo AA, Muñoz-Cardona ML, Restrepo-Erazo K, Vargas-Uricoechea H, Mejía-López MG.   +10 more
europepmc   +1 more source

Treatment of a Large Cohort of Childhood Chronic Noninfectious Uveitis in a Multicentric Large Study: Adalimumab Versus Methotrexate as First‐Line Therapy

Arthritis &Rheumatology, EarlyView.
Objective Treatment of childhood chronic idiopathic uveitis (cCIU) is predominantly based on studies in juvenile idiopathic arthritis–associated uveitis and expert opinion. Our aim was to report the treatment outcomes of our cohort of cCIU. Methods Retrospective multicenter study involving the rheumatology and ophthalmology units at Florence, Italy ...
Ilaria Maccora, Catherine Guly, Cinzia de Libero, Giulia Carreras, Athimalaipet V. Ramanan, Gabriele Simonini   +5 more
wiley   +1 more source

Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocol. [PDF]

BMJ Open
Fisher BA, Rowe A, Hodson C, Wilkhu M, Williams E, Turner E, Allard A, Blake T, Bombardieri M, Cope AP, Dubey S, Mankia K, Malley T, Moore O, Payne M, Plummer R, Tilby M, Tillett T, Wong E, Wu Y, Filer A, Pratt A, Pallan L, Homer V.   +23 more
europepmc   +1 more source

OP25. NEW GLUCOCORTICOIDS: SELECTIVE GLUCOCORTICOID RECEPTOR AGONISTS, NO-GLUCOCORTICOIDS AND LONG-CIRCULATING LIPOSOMAL GLUCOCORTICOIDS [PDF]

Rheumatology, 2005
openaire   +1 more source

Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study

Arthritis &Rheumatology, EarlyView.
Objective To evaluate the efficacy and safety of guselkumab, an interleukin‐23p19 subunit inhibitor, in participants with active psoriatic arthritis (PsA) and inadequate response (inadequate efficacy and/or intolerance) to one prior tumor necrosis factor (TNF) inhibitor.
Alexis Ogdie, Joseph F. Merola, Philip J. Mease, Christopher T. Ritchlin, Jose U. Scher, Kimberly Parnell Lafferty, Daphne Chan, Soumya D. Chakravarty, Wayne Langholff, Yanli Wang, Jie Shao, Yevgeniy Krol, Alice B. Gottlieb   +12 more
wiley   +1 more source

Low fruit and vegetable intake in children: a dietary stressor raising renal ammonium and adrenal cortisol secretion. [PDF]

Pflugers Arch
Remer T, Hua Y, Esche J, Shi L, Hartmann MF, Wudy SA.   +5 more
europepmc   +1 more source

INVITED REVIEW: The usefulness of measuring glucocorticoids for assessing animal welfare.

Journal of Animal Science, 2016
C. Ralph, A. Tilbrook
semanticscholar   +1 more source

A Metabolomic Signature Predicts Gout Flare Clinical Outcome Associated With Colchicine Prophylaxis

Arthritis &Rheumatology, EarlyView.
Objective This study investigated that serum metabolomics, before urate‐lowering therapy (ULT) initiation, could serve as a biomarker for responsiveness to colchicine prophylaxis in patients with gout commencing treat‐to‐target ULT. Methods We studied a multicenter prospective cohort (n = 409) initiating treat‐to‐target ULT plus colchicine prophylaxis.
Wenyan Sun, Lingfang Xu, Haibing Chen, Mingshu Sun, Zhiqiang Li, Rui Li, Lidan Ma, Hui Zhang, Aichang Ji, Yuwei He, Na Wu, Le Yan, Robert Terkeltaub, Changgui Li   +13 more
wiley   +1 more source